500126 Stock Overview
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Procter & Gamble Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,124.10 |
| 52 Week High | ₹5,835.95 |
| 52 Week Low | ₹4,640.30 |
| Beta | 0.51 |
| 11 Month Change | 0.29% |
| 3 Month Change | -1.42% |
| 1 Year Change | 1.02% |
| 33 Year Change | 1.93% |
| 5 Year Change | 20.91% |
| Change since IPO | 124,573.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500126 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.4% | -0.2% | 0.3% |
| 1Y | 1.0% | 40.5% | 27.3% |
Return vs Industry: 500126 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 500126 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 500126 volatility | |
|---|---|
| 500126 Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500126 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500126's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,407 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands.
Procter & Gamble Health Limited Fundamentals Summary
| 500126 fundamental statistics | |
|---|---|
| Market cap | ₹85.24b |
| Earnings (TTM) | ₹2.18b |
| Revenue (TTM) | ₹11.60b |
39.1x
P/E Ratio7.3x
P/S RatioIs 500126 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500126 income statement (TTM) | |
|---|---|
| Revenue | ₹11.60b |
| Cost of Revenue | ₹3.31b |
| Gross Profit | ₹8.28b |
| Other Expenses | ₹6.11b |
| Earnings | ₹2.18b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 131.17 |
| Gross Margin | 71.42% |
| Net Profit Margin | 18.77% |
| Debt/Equity Ratio | 1.8% |
How did 500126 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield91%
Payout RatioDoes 500126 pay a reliable dividends?
See 500126 dividend history and benchmarks| Procter & Gamble Health dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Jan 04 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 43 days |
Does 500126 pay a reliable dividends?
See 500126 dividend history and benchmarks